Literature DB >> 11778286

[Cancer pain and its influence on cancer patients' quality of life].

J Nie1, S Liu, L Di.   

Abstract

OBJECTIVE: To study cancer pain and its effect on cancer patients' quality of life.
METHODS: Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) and Brief Pain Inventory (BPI) methods were used to investigate cancer pain, its effect on patients' quality of life and management in 200 cancer inpatients.
RESULTS: The incidence of cancer pain was 69%, including 21.5% with mild pain, 19% with moderate pain and 28.5% with severe pain. Moderate and severe pain occurred more frequently in patients with cancer of the digestive tract. No correlation was found between pain and stage of the disease, but was closely associated with bone metastasis. Regardless of its severity, cancer pain seriously affected patients general activity, mood, walking ability, normal work and sleep. With the seriousness of pain, the patients were more affected. However, there was no obvious difference between moderate and severe pain in terms of their effect on the patients' joy of life and relations with people. The effect of moderate pain on patients' mentality appeared earlier than did severe pain. Among patients with cancer pain, 41.3% of them did not receive proper treatment. Only 52.1% of patients with severe pain were given strong opioids, which is far from the anti-pain standard set forth by the WHO.
CONCLUSION: Cancer pain is one of the most important factors which affect cancer patients' quality of life. For adequate control of cancer pain, there is still a long way to go to achieve WHO's goal.

Entities:  

Mesh:

Year:  2000        PMID: 11778286

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  1 in total

1.  Effects of depression on parameters of cell-mediated immunity in patients with digestive tract cancers.

Authors:  Ke-Jun Nan; Yong-Chang Wei; Fu-Ling Zhou; Chun-Li Li; Chen-Guang Sui; Ling-Yun Hui; Cheng-Ge Gao
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.